Hereditary spherocytosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Template) |
Amar Morani (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
* In general, once the diagnosis and baseline severity of HS in a child are established, it is not necessary to perform repeated blood tests unless there is an additional clinical indication (such as intercurrent infection and pallor, or an increase in jaundice). A routine annual review is usually sufficient together with an open door policy for potential complications such as parvovirus infection, or abdominal pain, which may trigger investigation for gallstones. | |||
==References== | ==References== | ||
Revision as of 08:45, 2 August 2018
|
Hereditary spherocytosis Microchapters |
|
Differentiating Hereditary spherocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hereditary spherocytosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hereditary spherocytosis secondary prevention |
|
Risk calculators and risk factors for Hereditary spherocytosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Secondary Prevention
- In general, once the diagnosis and baseline severity of HS in a child are established, it is not necessary to perform repeated blood tests unless there is an additional clinical indication (such as intercurrent infection and pallor, or an increase in jaundice). A routine annual review is usually sufficient together with an open door policy for potential complications such as parvovirus infection, or abdominal pain, which may trigger investigation for gallstones.